EDRH
Edmond de Rothschild Holding Portfolio holdings
AUM
$6.27B
1-Year Return
12.7%
This Quarter Return
-0.44%
1 Year Return
+12.7%
3 Year Return
+61.82%
5 Year Return
+120.93%
10 Year Return
+216.28%
AUM
$3.13B
AUM Growth
-$610M
(-16%)
Cap. Flow
-$710M
Cap. Flow
% of AUM
-22.64%
Top 10 Holdings %
Top 10 Hldgs %
21.56%
Holding
891
New
65
Increased
179
Reduced
291
Closed
69
Top Buys
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$13.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$12.8M |
| 3 |
ENDP
Endo International plc
ENDP
|
+$11.3M |
| 4 |
Franco-Nevada
FNV
|
+$10.9M |
| 5 |
Micron Technology
MU
|
+$10.6M |
Top Sells
| 1 |
Stellantis
STLA
|
+$46.6M |
| 2 |
Medtronic
MDT
|
+$42.9M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$40.1M |
| 4 |
Merck
MRK
|
+$38.2M |
| 5 |
UBS Group
UBS
|
+$31.6M |
Sector Composition
| 1 | Financials | 18.04% |
| 2 | Healthcare | 15.55% |
| 3 | Technology | 12.39% |
| 4 | Industrials | 9.88% |
| 5 | Consumer Discretionary | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
PTC
PTC
$24.4B
| $524K | 0.02% |
15,800
-1,000
| -6% | -$33.2K |
|
327
Kinross Gold
KGC
$27.3B
| $519K | 0.02% |
151,700
-67,000
| -31% | -$229K |
|
|
BHI
328
DELISTED
Baker Hughes
BHI
| $517K | 0.02% |
11,800
+700
| +6% | +$30.7K |
|
329
Quest Diagnostics
DGX
$20.4B
| $514K | 0.02% |
7,200
| – | – |
|
330
Comcast
CMCSA
$124B
| $512K | 0.02% |
16,760
-7,134
| -30% | -$218K |
|
331
iShares US Financials ETF
IYF
$4.03B
| $508K | 0.02% |
12,008
-19,660
| -62% | -$832K |
|
332
Vanguard FTSE Emerging Markets ETF
VWO
$98.5B
| $500K | 0.02% |
14,460
| – | – |
|
|
DANG
333
DELISTED
E-COMMERCE CHINA DANGDANG INC SPNSRD ADS REP COM CL A (CYM)
DANG
| $499K | 0.02% |
70,000
+2,900
| +4% | +$20.7K |
|
334
NXP Semiconductors
NXPI
$56.4B
| $494K | 0.02% |
6,090
+740
| +14% | +$60K |
|
335
Vanguard Consumer Discretionary ETF
VCR
$6.52B
| $486K | 0.02% |
3,922
-515
| -12% | -$63.8K |
|
336
Oracle
ORCL
$678B
| $483K | 0.02% |
11,798
-2,500
| -17% | -$102K |
|
337
Gerdau
GGB
$6.19B
| $469K | 0.01% |
332,010
+275,310
| +486% | +$389K |
|
338
Carlyle Group
CG
$23B
| $468K | 0.01% |
+27,735
| New | +$468K |
|
339
Teva Pharmaceuticals
TEVA
$22.6B
| $467K | 0.01% |
8,668
+2,090
| +32% | +$113K |
|
340
iShares 3-7 Year Treasury Bond ETF
IEI
$16.9B
| $462K | 0.01% |
3,671
+320
| +10% | +$40.3K |
|
341
Eli Lilly
LLY
$673B
| $462K | 0.01% |
6,410
+910
| +17% | +$65.6K |
|
342
Ormat Technologies
ORA
$5.46B
| $460K | 0.01% |
11,171
+1,710
| +18% | +$70.4K |
|
343
VanEck Biotech ETF
BBH
$355M
| $459K | 0.01% |
4,425
-10,775
| -71% | -$1.12M |
|
344
Bunge Global
BG
$16.8B
| $456K | 0.01% |
8,045
-390
| -5% | -$22.1K |
|
345
Banco Macro
BMA
$2.82B
| $455K | 0.01% |
7,059
+5,259
| +292% | +$339K |
|
346
Blackstone Mortgage Trust
BXMT
$3.41B
| $454K | 0.01% |
16,896
+15,896
| +1,590% | +$427K |
|
347
iShares Floating Rate Bond ETF
FLOT
$9.12B
| $453K | 0.01% |
8,975
-4,720
| -34% | -$238K |
|
348
Apollo Global Management
APO
$76.9B
| $452K | 0.01% |
+26,427
| New | +$452K |
|
349
Carnival Corp
CCL
$42.8B
| $452K | 0.01% |
8,560
| – | – |
|
350
AbbVie
ABBV
$372B
| $449K | 0.01% |
7,867
-300
| -4% | -$17.1K |
|